Supernus Pharmaceuticals | SUPN - Zysk Z Działalności Operacyjnej





Zysk Z Działalności Operacyjnej Zmiana Data
Abbott USD 1.85B 399M 2026-03
ANI Pharmaceuticals USD 38.71M 9.58M 2026-03
Aurora Cannabis CAD -35.79M 19.88M 2025-12
Bristol-Myers Squibb USD 4.2B 562M 2025-12
Canopy Growth CAD -12.66M 1.64M 2025-12
Cara Therapeutics USD -5.94M 3.55M 2025-09
Corcept Therapeutics USD -49.6M 54.09M 2026-03
Eisai JPY -10.31B 30.35B 2026-03
Eli Lilly USD 9.78B 792M 2026-03
Novo Nordisk DKK 59.62B 27.24B 2026-03
Pacira USD 4.62M 1.43M 2026-03
Perrigo USD 33.6M 50.8M 2026-03
Pfizer USD 4.99B 340M 2026-03
Supernus Pharmaceuticals USD -35.25M 49.07M 2026-03
United Therapeutics USD 325.8M 340.4M 2026-03
Xeris Pharmaceuticals USD 16.77M 10.04M 2025-12